INTRAVENOUS (IV) IBUPROFEN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Patent expiration of intravenous (IV) ibuprofen products is expected to face lower-cost generic competition, which can significantly impact the revenues of existing intravenous (IV) ibuprofen players. This may lead to loss of market share for branded products.

Market Opportunities – Increasing Number of Orthopedic Surgeries

There is an increasing number of orthopedic surgeries being conducted minimally invasively such as arthroscopic and endoscopic procedures. Such surgeries require intravenous anti-inflammatory drugs like ibuprofen for post-operative pain management. This rising trend can boost the demand for intravenous (IV) formulation of ibuprofen.